Alibaba Health Information Technology Ltd (ALBBY)
8.62
0.00 (0.00%)
USD |
OTCM |
Jun 27, 16:00
Alibaba Health Information Technology Enterprise Value: 5.273B for June 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 26, 2024 | 5.273B |
| June 25, 2024 | 5.273B |
| June 24, 2024 | 5.273B |
| June 21, 2024 | 5.273B |
| June 20, 2024 | 5.273B |
| June 18, 2024 | 5.273B |
| June 17, 2024 | 5.273B |
| June 14, 2024 | 5.273B |
| June 13, 2024 | 5.273B |
| June 12, 2024 | 5.273B |
| June 11, 2024 | 5.273B |
| June 10, 2024 | 5.273B |
| June 07, 2024 | 5.273B |
| June 06, 2024 | 5.273B |
| June 05, 2024 | 5.273B |
| June 04, 2024 | 5.273B |
| June 03, 2024 | 5.366B |
| May 31, 2024 | 5.366B |
| May 30, 2024 | 5.366B |
| May 29, 2024 | 5.366B |
| May 28, 2024 | 5.366B |
| May 24, 2024 | 4.492B |
| May 23, 2024 | 4.492B |
| May 22, 2024 | 4.388B |
| May 21, 2024 | 4.919B |
| Date | Value |
|---|---|
| May 20, 2024 | 4.684B |
| May 17, 2024 | 4.684B |
| May 16, 2024 | 4.684B |
| May 15, 2024 | 4.684B |
| May 14, 2024 | 4.684B |
| May 13, 2024 | 4.684B |
| May 10, 2024 | 4.684B |
| May 09, 2024 | 4.684B |
| May 08, 2024 | 4.684B |
| May 07, 2024 | 4.684B |
| May 06, 2024 | 4.848B |
| May 03, 2024 | 4.742B |
| May 02, 2024 | 3.881B |
| May 01, 2024 | 3.881B |
| April 30, 2024 | 3.881B |
| April 29, 2024 | 3.881B |
| April 26, 2024 | 3.881B |
| April 25, 2024 | 3.881B |
| April 24, 2024 | 3.881B |
| April 23, 2024 | 3.881B |
| April 22, 2024 | 3.881B |
| April 19, 2024 | 3.881B |
| April 18, 2024 | 3.881B |
| April 17, 2024 | 4.154B |
| April 16, 2024 | 4.154B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.440B
Minimum
Oct 24 2022
51.35B
Maximum
Feb 17 2021
16.08B
Average
8.468B
Median
Enterprise Value Benchmarks
| Sinovac Biotech Ltd | -7.191B |
| CASI Pharmaceuticals Inc | 46.97M |
| Zai Lab Ltd | 1.171B |
| Adagene Inc | 44.47M |
| LakeShore Biopharma Co Ltd | 96.03M |
Enterprise Value Related Metrics
| Earnings Yield | 1.98% |
| Operating Earnings Yield | 0.81% |
| Normalized Earnings Yield | 1.564 |